The FDA commissioner is a gifted talker — but the job is about more than that

Taking stock of the drug industry, from the lab to the medicine chest

July 14, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Anna Moneymaker/Getty Images STAT+ | The FDA commissioner is a gifted talker — but the job is about more than that While Marty Makary's ideas for the agency are ambitious on first blush, they merit more scrutiny — and they don't always hold up. By Matthew Herper Ozempic for addiction: How an elite rehab center is using GLP-1s to 'obliterate' all kinds of cravings Caron Treatment Centers use GLP-1 drugs in addiction treatment. Doctors say Ozempic has "obliterated" patients' cravings for opioids and alcohol. By Lev Facher and Rachel Wisniewski STAT+ | The growing influence of vaccine skeptics inside HHS Lyn Redwood, former president of the anti-vaccine group Children's Health Defense, is the latest vaccine critic hired by HHS Secretary Robert F. Kennedy Jr. By Chelsea Cirruzzo Alex Hogan/STAT STAT+ | Up and down the ladder: The latest comings and goings From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry. By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser